Hasil Pencarian - Ari VanderWalde

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma

    180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma oleh Ari VanderWalde, Andrew Elliott, George Ansstas, Soo Park, Kevin Kim, George P Souroullas, Tolulope Adeyelu

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    495 Basal cell carcinoma demonstrates a T-cell exclusion immune phenotype in contrast to other anti-PD-1 therapy responsive cutaneous malignancies

    495 Basal cell carcinoma demonstrates a T-cell exclusion immune phenotype in contrast to other anti-PD-1 therapy responsive cutaneous malignancies oleh Geoffrey Gibney, Ari VanderWalde, Joanne Xiu, Joseph Drabick, Gino In, Steven O’Day, Kelsey Poorman, W Korn

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC)

    1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC) oleh James L Gulley, Ari VanderWalde, Emil Lou, Nishant Gandhi, Heloisa Soares, Charalampos S Floudas, Dara Bracken-Clarke, Harris Krause, Minh Phan, Rusha Patel, Phillip Walker

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal undifferentiated carcinoma (SNUC)

    1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal u... oleh James L Gulley, Ari VanderWalde, Emil Lou, Nishant Gandhi, Heloisa Soares, Charalampos S Floudas, Dara Bracken-Clarke, Harris Krause, Alex Farrell, Minh Phan, Rusha Patel, Nyall London

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors

    506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors oleh Anna Olsson-Brown, Joseph Sacco, Mark Middleton, Jason Chesney, Mohammed Milhem, Kevin Harrington, Robert Coffin, Katy Tsai, Adel Samson, Bartosz Chmielowski, Ari VanderWalde, Andrea Pirzkall, Jiaxin Niu, Praveen Bommareddy, Georgia Beasley, Gino In, Terence Rhodes, Francesca Aroldi, Lavita Menezes, Tawnya Bowles, Hamid Emamekhoo, Scott Baum, Sophie Dalac-Rat, Katharina Kahler, Eva Muñoz

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: